In the fast-evolving botanicals market, maintaining the potency of active agents is crucial. We are dedicated to preserving the therapeutic benefits of botanical compounds, with a focus on acidic cannabinoids like CBDA and THCA.
Introducing @LDH™ Technology:
Our patent-pending @LDH™ technology achieves over 90% encapsulation efficiency for acidic cannabinoids, ensuring maximum potency and stability.
Key benefits include:
- Stabilization and Protection: Particularly effective for CBDA, CBGA, THCA, and THCVA.
- Temperature Resilience: Eliminates the need for complex cold storage by providing unparalleled protection from elevated temperatures.
- Prevention of Degradation: Prevents decarboxylation and oxidation.
- Precise Dosing: Ensures accurate and consistent dosing.
- Avoidance of New Chemical Entities (NCEs): Maintains the integrity of the original compounds.
- Versatile Delivery Options: Offers taste and smell masking for diverse application methods.
Our formulation employs cost-effective ingredients and standard pharmaceutical processes, resulting in @LDH™ intercalated material. These intercalates ensure efficient delivery, can be tailored for various administration routes, and meet stringent regulatory standards.
Mingowood Pharmacal
Copyright © 2024 Mingowood Pharmacal - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.